Dsp Healthcare Fund
DSP Mutual Fund · FM: Chirag Dagli · INF740KA1LG1 · Direct
NAV ₹51.66 AUM ₹3630 Cr as of 21 Sep 2026
Portfolio as of Jul 2026 · Last Update: 16-Aug-2026 05:02 PM IST
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | +0.7% | +1.3% | +11.0% | +29.4% | +16.4% | +23.3% | +15.9% | 33/234 | 0.75% |
Equity allocation
84.32%
Non-equity allocation (combined)
15.68%
All Equity Holdings (25) as of Jul 2026
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd | 305.7 | 8.42% | — |
| 2 | IPCA Laboratories Ltd | 296.5 | 8.17% | — |
| 3 | Cipla Ltd | 294.8 | 8.13% | — |
| 4 | Sai Life Sciences Ltd | 257.4 | 7.10% | — |
| 5 | Gland Pharma Ltd | 230.4 | 6.35% | — |
| 6 | Apollo Hospitals Enterprise Ltd | 210.9 | 5.81% | — |
| 7 | Alkem Laboratories Ltd | 169.0 | 4.66% | — |
| 8 | Cohance Lifesciences Ltd | 136.1 | 3.75% | — |
| 9 | Vijaya Diagnostic Centre Ltd | 125.8 | 3.47% | — |
| 10 | Alembic Pharmaceuticals Ltd | 115.0 | 3.17% | — |
| 11 | Manipal Health Enterprises Ltd^ | 109.7 | 3.02% | — |
| 12 | Procter & Gamble Health Ltd | 105.2 | 2.90% | — |
| 13 | Kovai Medical Center And Hospital Ltd | 99.3 | 2.74% | — |
| 14 | Pfizer Ltd | 99.2 | 2.73% | — |
| 15 | Divi's Laboratories Ltd | 84.8 | 2.34% | — |
| 16 | Indoco Remedies Ltd | 71.2 | 1.96% | — |
| 17 | Concord Biotech Ltd | 70.6 | 1.95% | — |
| 18 | Unichem Laboratories Ltd | 57.7 | 1.59% | — |
| 19 | Syngene International Ltd | 48.2 | 1.33% | — |
| 20 | Nephrocare Health Services Ltd | 43.3 | 1.19% | — |
| 21 | ICICI Lombard General Insurance Co Ltd | 39.2 | 1.08% | — |
| 22 | Aarti Drugs Ltd | 36.0 | 0.99% | — |
| 23 | Eris Lifesciences Ltd | 30.6 | 0.84% | — |
| 24 | Jupiter Life Line Hospitals Ltd | 17.1 | 0.47% | — |
| 25 | Laxmi Dental Ltd | 6.0 | 0.16% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.